Anti-GBP2 antibody (200-250 aa) (STJ13101189)
SPECIFICATIONS
ClonalityPolyclonal
HostRabbit
ConjugationUnconjugated
IsotypeIgG
ImmunogenA synthetic peptide from aa region 200-250 of human GBP2 conjugated to an immunogenic carrier protein was used as the antigen.
General Information
| Short Description | Rabbit polyclonal anti-GBP2 (200-250 aa) for use in IHC and WB in Human samples. Datasheet included with dilution recommendations, and related reagents. |
| Applications | IHC/WB |
| Host | Rabbit |
| Reactivity | Human |
| Note | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Product Properties
| Clonality | Polyclonal |
| Isotype | IgG |
| Conjugation | Unconjugated |
| Purification | IgG purified |
| Dilution Range | IHC, WB (confirmed by recombinant protein). A dilution of 1:300 to 1:2000 is recommended. The optimal dilution should be determined by the end user. Not yet tested in other applications. |
| Formulation | Lyophilised |
| Storage Instruction | Maintain the lyophilised/reconstituted antibodies frozen at-20°C for long term storage and refrigerated at 2-8°C for a shorter term. When reconstituting, Glycerol (1:1) may be added for an additional stability. Avoid freeze and thaw cycles. |
Target Information
| Gene Symbol | GBP2 |
| Gene ID | 2634 |
| Uniprot ID | GBP2_HUMAN |
| Immunogen | A synthetic peptide from aa region 200-250 of human GBP2 conjugated to an immunogenic carrier protein was used as the antigen. |
| Immunogen Region | 200-250 aa |
| Specificity | Specific for GBP2. |
Additional Info
| Function | Interferon (IFN)-inducible GTPase that plays important roles in innate immunity against a diverse range of bacterial, viral and protozoan pathogens. Hydrolyzes GTP to GMP in 2 consecutive cleavage reactions, but the major reaction product is GDP. Following infection, recruited to the pathogen-containing vacuoles or vacuole-escaped bacteria and acts as a positive regulator of inflammasome assembly by promoting the release of inflammasome ligands from bacteria. Acts by promoting lysis of pathogen-containing vacuoles, releasing pathogens into the cytosol. Following pathogen release in the cytosol, promotes recruitment of proteins that mediate bacterial cytolysis: this liberates ligands that are detected by inflammasomes, such as lipopolysaccharide (LPS) that activates the non-canonical CASP4/CASP11 inflammasome or double-stranded DNA (dsDNA) that activates the AIM2 inflammasome. Confers protection to the protozoan pathogen Toxoplasma gondii. Independently of its GTPase activity, acts as an inhibitor of various viruses infectivity, such as HIV-1, Zika and influenza A viruses, by inhibiting FURIN-mediated maturation of viral envelope proteins. |
| Protein Name | Guanylate-Binding Protein 2Gtp-Binding Protein 2Gbp-2Hugbp-2Guanine Nucleotide-Binding Protein 2Interferon-Induced Guanylate-Binding Protein 2 |
| Database Links | Reactome: R-HSA-877300Reactome: R-HSA-909733 |
| Cellular Localisation | Cytoplasmic Vesicle MembraneLipid-AnchorGolgi Apparatus MembraneCytoplasmPerinuclear RegionGbp2-Gbp5 Dimers Localize To The Golgi Apparatus |
| Alternative Antibody Names | Anti-Guanylate-Binding Protein 2 antibodyAnti-Gtp-Binding Protein 2 antibodyAnti-Gbp-2 antibodyAnti-Hugbp-2 antibodyAnti-Guanine Nucleotide-Binding Protein 2 antibodyAnti-Interferon-Induced Guanylate-Binding Protein 2 antibodyAnti-GBP2 antibody |
Information sourced from Uniprot.org